At Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing.
We believe our people are at the core of everything we do, and we’re committed to cultivating a culture where every individual feels valued and included. To do this, we strive to integrate belonging, inclusivity, diversity, and equity into every aspect of our organization.
Together, we are leading the way towards a healthier and more equitable future.
The Drug Safety and Pharmacovigilance (DSPV) Scientist Associate Director/Director will provide critical DSPV quality and operational support for all Editas Medicine products throughout the life-cycle. The incumbent will support the medical component of DSPV activities including aggregate reports, signaling and risk management activities, individual case safety reports, and safety vendor oversight. This individual will collaborate closely with the safety physician and cross-functional partners to monitor, evaluate and actively manage safety risks in accordance with global regulatory frameworks.
Responsibilities:
Provide DSPV support and representation for Editas Medicine’s clinical developmental programs in close collaboration with Clinical Development, Clinical Operations, Medical Affairs, Regulatory, Data Management and Biostatistics/Programming
Establish successful working relationships with, and provide oversight to CROs and other vendors for day-to-day DSPV activities including but not limited to case processing and aggregate reports
Carry out routine DSPV safety signal management activities including performing case series review and tabulated/line-listings data review for identifying and assessing safety signals and adequately documenting discussions, conclusions, and decisions
Support activities in preparation of aggregate safety reports (e.g. DSURs, PBERs, etc.) including project management, safety data requests, providing contents to assigned section assimilating information from other groups, and performing data verification checks
Review and provide DSPV input for development of protocols, IBs, SAPs, CSRs, and other relevant project/study documents
Participate in clinical trial activities, including coding review, SAE reconciliation, etc.
Provide DSPV input for regulatory submissions and regulatory responses, and collaborating with cross-functional areas as appropriate
Participate in safety-led meetings, including the Safety Review Committee (SRC), Independent Data Monitoring Committee (IDMC) meetings, and other safety-related presentations
Contribute to health authority and other safety related query responses
Assist with writing/review and maintenance of Safety Monitoring Plans, Safety Data Exchange Agreements, DSPV Standard Operating Procedures, etc.
Participate in inspection readiness activities and preparation as needed
Participates in literature surveillance activities
Actively involved in process improvement and compliance activities
Participate in project specific internal teleconferences/meetings and client specific teleconferences/meetings for operations.
Alert DSPV management for any identification/escalation of issues
Other tasks and responsibilities as required
Requirements
Qualifications:
Degree in Pharmacy, Nursing, Epidemiology, or equivalent healthcare degree with pharmaceutical industry background preferred; Applicants with more than 10 years of experience in Drug Safety and Pharmacovigilance may be considered
Minimum 7 years (10 years for Director level) of pharmaceutical experience, preferably in Drug Safety and Pharmacovigilance
Knowledge of GCPs, ICH guidelines, and FDA, EMA, and other international regulations
Experience with safety databases (ARGUS, ARISg, or other safety database applications), electronic data capture (EDC) systems, and electronic document management systems
Experience and extensive working knowledge of MedDRA, WHO-DRUG, and safety databases
Experience with clinical development including risk/benefit analysis and safety assessment
Experience reviewing cumulative safety data with ability to interpret, synthesize and communicate complex safety information
Experience with the compilation, writing and reviewing of safety documents such as DSURs, IB, PBRERs/PADERs, responses to Health Authority, submission documents, and safety labels
Strong relationship-building skills, with ability to interact effectively in a multifunctional, multicultural, growing organization; Able to work independently and in a team environment
Proficient in standard computer software (Word, Excel, and Power point presentations)
Strategic thinking, strong organizational and analytic skills, project management, excellent verbal, written communication skills, attention to details
Excellent organizational skills and demonstrated ability to multi-task in a fast-paced environment with changing priorities
Excellent written and verbal communication skills; able to interact across multiple functions
Exhibits comprehension of industry practices and regulations for drug development and pharmacovigilance
Gene-therapy safety science experience a plus, but not required
Benefits
Benefits Summary:
Editas provides a comprehensive array of benefits to all employees, including a Blue Cross Blue Shield PPO Medical Plan, a company-funded Health Savings Account, Dental and Vision Insurance, Life and Disability Insurance, Dependent Care Account, Tuition Reimbursement, 401(k) plan with company match, Employee Stock Purchase Plan, Employee Assistance Plan, Wellness Programs, and a flexible Paid Time Off policy.
If you are a results-focused and collaborative professional with a passion for advancing transformative therapies, we invite you to apply. Join us at the forefront of genetic innovation and be a key contributor to Editas Medicine's mission of redefining healthcare through cutting-edge genetic technologies.
Fostering Belonging. Fueling Innovation. Transforming Lives.